Omalizumab Relieves Aspirin-Exacerbated Respiratory Disease Omalizumab Relieves Aspirin-Exacerbated Respiratory Disease

Omalizumab reduces aspirin hypersensitivity and lowers leukotriene E4 (LTE4) levels in patients with aspirin-exacerbated respiratory disease (AERD), researchers in Japan report.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news